Bortezomib/Rituximab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bortezomib and rituximab that may be used for the treatment of some forms of non-Hodgkin's lymphoma (NHL), such as follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma and post-transplant lymphoproliferative disorder (PTLD).
**Synonyms:** - Bortezomib Plus Rituximab - Bortezomib and Rituximab (VR) - Bortezomib and Rituximab-abbs (VR) - Bortezomib and Rituximab-arrx (VR) - Bortezomib and Rituximab-blit (VR) - Bortezomib and Rituximab-pvvr (VR) - Bortezomib and Rituximab-rite (VR) - Bortezomib and Rituximab-rixa (VR) - Bortezomib and Rituximab-rixi (VR) - Bortezomib-Rituximab - Bortezomib-Rituximab Regimen - Bortezomib/Rituximab - Rituximab-Bortezomib - Rituximab/Bortezomib - Velcade/Rituxan
/api/v1/systems/nci_thesaurus/nodes/C188467Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.